935
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Successful treatment of acute lymphoblastic leukemia (ALL) during pregnancy using a pediatric-based protocol incorporating pegylated asparaginase

ORCID Icon, , , , , , , , , , & show all
Pages 1880-1883 | Received 03 Jun 2023, Accepted 14 Jul 2023, Published online: 30 Jul 2023

References

  • Rizack T, Mega A, Legare R, et al. Management of hematological malignancies during pregnancy. Am J Hematol. 2009;84(12):830–841. doi:10.1002/ajh.21547
  • Voulgaris E, Pentheroudakis G, Pavlidis N. Cancer and pregnancy: a comprehensive review. Surg Oncol. 2011;20(4):e175–e185. doi:10.1016/j.suronc.2011.06.002
  • Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol. 2004;5(5):283–291. doi:10.1016/S1470-2045(04)01466-4
  • Grace RF, Dahlberg SE, Neuberg D, et al. The frequency and management of asparaginase‐related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana‐Farber Cancer Institute consortium protocols. Br J Haematol. 2011;152(4):452–459. doi:10.1111/j.1365-2141.2010.08524.x
  • Rizack T, Perez K, Strenger R. 2015. Special Hematologic Issues in the Pregnant Patient. In: Rosene-Montella, K, editor. Medical Management of the Pregnant Patient. New York (NY): Springer. doi:10.1007/978-1-4614-1244-1_7
  • Zaidi A, Johnson L-M, Church CL, et al. Management of concurrent pregnancy and acute lymphoblastic malignancy in teenaged patients: two illustrative cases and review of the literature. J Adolesc Young Adult Oncol. 2014;3(4):160–175. doi:10.1089/jayao.2014.0014
  • Parovichnikova EN, Troitskaya VV, Gavrilina OA, et al. The outcome of Ph-negative acute lymphoblastic leukemia presenting during pregnancy and treated on the Russian prospective multicenter trial RALL-2009. Leuk Res. 2021;104:106536. doi:10.1016/j.leukres.2021.106536
  • Zhu D, Tang D, Chai X, et al. Acute leukemia in pregnancy: a single institutional experience with 21 cases at 10 years and a review of the literature. Ann Med. 2021;53(1):567–575. doi:10.1080/07853890.2021.1908586
  • Wang P, Yang Z, Shan M, et al. Maternal and fetal outcomes of acute leukemia in pregnancy: a retrospective study of 52 patients. Front Oncol. 2021;11:803994. doi:10.3389/fonc.2021.803994
  • Farhadfar N, Cerquozzi S, Hessenauer MR, et al. Acute leukemia in pregnancy: a single institution experience with 23 patients. Leuk Lymph. 2017;58(5):1052–1060. doi:10.1080/10428194.2016.1222379
  • Blatt J, Mulvihill JJ, Ziegler JL, et al. Pregnancy outcome following cancer chemotherapy. Am J Med. 1980;69(6):828–832. doi:10.1016/s0002-9343(80)80007-6
  • Hansen WF, Fretz P, Hunter SK, et al. Leukemia in pregnancy and fetal response to multiagent chemotherapy. Obstet Gynecol. 2001;97(5 Pt 2):809–812.
  • Karp G, Von Oeyen P, Valone F, et al. Doxorubicin in pregnancy: possible transplacental passage. Cancer Treat Rep. 1983;67(9):773–777.
  • Matsouka C, Marinopoulos S, Barbaroussi D, et al. Acute lymphoblastic leukemia during gestation. Med Oncol. 2008;25(2):190–193. doi:10.1007/s12032-007-9024-0
  • Bottsford-Miller J, Haeri S, Baker AM, et al. B cell acute lymphocytic leukemia in pregnancy. Arch Gynecol Obstet. 2011;284(2):303–306. doi:10.1007/s00404-010-1647-2